Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02186535 · ClinicalTrials.gov registry record · Phase 1
The Role of Vitamin D in Female Reproductive Tract Immunity
A Phase 1 study, sponsored by CONRAD.
- Completed
- Registry status
- Phase 1
- Development phase
- 22
- Enrollment target
NCT02186535 is a Phase 1 study that has completed, run by CONRAD. The registered enrollment target is 22 participants.
The verdict
NCT02186535, a Phase 1 study, has completed, sponsored by CONRAD.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the impact of approximately 8 weeks of Vitamin D (VitD) and calcium supplementation, using daily versus weekly supplementation regimens, on female reproductive tract immunity.
Interventions
- DIETARY_SUPPLEMENT Vitamin D and Calcium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2014-08 |
| Est. Completion | 2015-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02186535
The ClinicalTrials.gov registry entry for NCT02186535 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is CONRAD, which has 33 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Vitamin D and Calcium is the first listed.
NCT02186535 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02186535 about?
NCT02186535 is a clinical study titled "The Role of Vitamin D in Female Reproductive Tract Immunity". The purpose of this study is to assess the impact of approximately 8 weeks of Vitamin D (VitD) and calcium supplementation, using daily versus weekly supplementation regimens, on female reproductive tract immunity.
What is the current status of trial NCT02186535?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 22 participants. The study started on 2014-08. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02186535?
The interventions under investigation include: Vitamin D and Calcium (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02186535?
This trial is sponsored by CONRAD, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.